Ontogeny-based Dosing

Ontogeny-Based Dosing is a pediatric drug dosing strategy that belongs to the category of pharmacokinetic and pharmacodynamic modeling approaches, distinguished by its explicit integration of age-dependent physiological and biochemical maturation processes to tailor drug doses according to the developmental stage of the individual.

5

Publications

317

Citations

35

Authors

17

Institutions

Publications per year

2017–2026

2

Authors

35

  1. PE
    Paul E. Milligan

    Washington University in St. Louis, United States

    1 publications · 178 citations

    1

    h-index

  2. RS
    R. Stephen J. Burnett

    Barnes-Jewish Hospital, United States

    1 publications · 178 citations

    1

    h-index

  3. DV
    Deepak Voora

    Duke University, United States

    1 publications · 178 citations

    1

    h-index

  4. LG
    Leonard Grosso

    Saint Louis University, United States

    1 publications · 178 citations

    1

    h-index

  5. GR
    Gloria R. Grice

    University of Health Sciences and Pharmacy, United States

    1 publications · 178 citations

    1

    h-index

1–5 of 35

Venues

  1. Blood

    1 publications · 178 citations

    1

    h-index

  2. British Journal of Clinical Pharmacology

    BJCP · 1 publications · 65 citations

    1

    h-index

  3. The Journal of Clinical Pharmacology

    1 publications · 37 citations

    1

    h-index

  4. Frontiers in Pediatrics

    1 publications · 21 citations

    1

    h-index

  5. Pharmaceutical Research

    1 publications · 16 citations

    1

    h-index

1–5